Nonalcoholic Fatty Liver Disease.


Journal Article

Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is the leading cause of chronic liver disease. Treatments target lifestyle modification and improvement of underlying risk factors. Noninvasive biomarkers for diagnosis and staging of NAFLD and safe, cost-effective treatments for patients with nonalcoholic steatohepatitis (NASH) and/or NASH-related cirrhosis are currently under investigation.

Full Text

Duke Authors

Cited Authors

  • Thrasher, T; Abdelmalek, MF

Published Date

  • May 2016

Published In

Volume / Issue

  • 77 / 3

Start / End Page

  • 216 - 219

PubMed ID

  • 27154894

Pubmed Central ID

  • 27154894

International Standard Serial Number (ISSN)

  • 0029-2559

Digital Object Identifier (DOI)

  • 10.18043/ncm.77.3.216


  • eng

Conference Location

  • United States